Spruce Biosciences Capital Expenditures (CapEx) Growth & History (SPRB)

Spruce Biosciences's capital expenditures (capex) was $0 for fiscal 2024.

View full Spruce Biosciences company overview

Spruce Biosciences annual capital expenditures (capex) history

Spruce Biosciences annual capital expenditures (capex)

Fiscal yearPeriod endedCapital expenditures (CapEx)ChangeGrowth
20242024-12-31$0−$7,000
20232023-12-31$7,000−$1,000−12.50%
20222022-12-31$8,000−$85,000−91.40%
20212021-12-31$93,000$19,000+25.68%
20202020-12-31$74,000$70,000+1750.00%
20192019-12-31$4,000

Spruce Biosciences capital expenditures (capex) trends

Over the last five fiscal years, Spruce Biosciences's capital expenditures (capex) decreased from $4,000 to $0, a change of −$4,000. The latest reported quarter, Q2 2026, shows $135,000.

About the metric

What capital expenditures (CapEx) mean

Capital expenditures, commonly called CapEx, are cash investments in long-lived assets such as property, plants, equipment, infrastructure, and productive software. CapEx can support future growth or maintain existing operations, but it reduces current-period free cash flow.

Calculation and source

SEC-reported capital expenditures

TickerStat standardizes cash payments for property, plant, equipment, and other productive assets reported in company SEC filings. When a filer reports separate qualifying CapEx components instead of a total, those components are combined for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Spruce Biosciences source filings ↗

Community posts

It’s quiet here.

No posts about SPRB yet. Start the conversation.

Write the first post